The estimated US$30.7 billion global market for diabetes diagnostics in 2022 is expected to grow at a compound annual growth rate (CAGR) of 8.6% to reach a revised US$ 59.3 billion by 2030.
.jpg
"The Global Diabetes Diagnostics Market 2020-2030 (USD Billion)")
The global diabetes diagnostics market is projected to grow on account of a growing incidence of diabetes coupled with the growing obese population and improper lifestyle patterns across the globe. For all healthcare providers and patients, the diagnosis and treatment of diabetes have long been complicated. It's never easy to keep up with daily exercise, diabetic diet schedules, drugs, and blood sugar tests. On a daily basis, diabetic patients require constant self-management. Analysis of blood sugar fluctuations and other variables involved in diabetes treatment is also a frustrating task for doctors. Management of diabetes and the risks associated with it is still a major concern in developed countries due to problems such as shortage of healthcare personnel, inadequate access to healthcare services, lack of knowledge among people and lack of information that makes for clinical decision-making.
The global diabetes diagnostics market is categorized based on product type, end-use, and region. Asia Pacific diabetes diagnostics market is anticipated to witness the fastest growth rate from 2020 to 2028. The regional growth is attributed to growing demand from emerging countries such as China and India. Both these countries are facing burden from its diabetic patient pool which is expected to grow over the course of the forecast period. This is antibiotics to fuel additives the growth of the Asia Pacific diabetes diagnostics industry.
The number of persons with diabetes conditions continues to grow per year. As stated by the World Health Organization (WHO), a total of 1 out of 13 persons are diagnosed with diabetes worldwide per year, and diabetes is also expected to be the 7th leading cause of death in 2030. The number of people diagnosed with diabetes have tripled over the past two decades and is one of the rising health problems across the globe. These figures are expected to grow and thus fuel the development of the global diabetes diagnostics market.
Diabetes Diagnostics Market scope
| Metrics | Details |
| Base Year | 2023 |
| Historic Data | 2018-2022 |
| Forecast Period | 2024-2030 |
| Study Period | 2018-2030 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2030 | US$ 59.3 billion |
| Growth Rate | CAGR of 8.6% during 2020-2030 |
| Segment Covered | Product Type,End-Use, Regions |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
| Key Players Profiled | BD, Johnson and Johnson, Roche Diagnostics Ltd, Bayer AG, Ypsomed AG, Abbott, Novo Nordisk A/S, Medtronic plc, Terumo Corporation, Acon Laboratories |
Key segments of the global diabetes diagnostics market
Product Type Overview, (USD Billion)
- Test Strips
- Lancets
- Analog Glucose Monitors
- Continuous Glucose Monitors
- Syringes
- Pens
- Pumps
- Injectors
End-Use Overview, (USD Billion)
- Hospitals/Clinics
- Homecare
- Diagnostic Centers
Regional Overview, (USD Billion)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- South America
- Brazil
- Mexico
- Rest of South America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East and Africa
Important Companies in Global Diabetes Diagnostics Market
- BD
- Johnson and Johnson
- Roche Diagnostics Ltd
- Bayer AG
- Ypsomed AG
- Abbott
- Novo Nordisk A/S
- Medtronic plc
- Terumo Corporation
- Acon Laboratories
Reasons for the study
- The purpose of the study is to give an exhaustive outlook of the global diabetes diagnostics industry
- The overall segmentation of diabetes diagnostics market, especially key segments are thoroughly studied.
- Presence of major players and their wide product portfolio across developed countries is anticipated to further boost the growth of diabetes diagnostics market
What does the report include?
- The study on the global diabetes diagnostics market includes analysis of qualitative market indicators such as drivers, restraints, challenges and opportunities
- Additionally, the market competition has been evaluated using the Porter’s five forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of product type, and end user. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the considered segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global diabetes diagnostics market is suitable for all the players across the value chain including raw material suppliers, diabetes diagnostics providers, medical device manufacturers, distributors, suppliers and retailers
- Venture capitalists and investors looking for more information on the future outlook of the global diabetes diagnostics market
Consultants, analysts, researchers, and academicians looking for insights shaping the global diabetes diagnostics market
Frequently Asked Questions (FAQ) :
The major contenders in the global market are BD, Johnson and Johnson, Roche Diagnostics Ltd, Bayer AG, Ypsomed AG, Abbott, Novo Nordisk A/S, Medtronic plc, Terumo Corporation, Acon Laboratories
The Global diabetes diagnostics market is Segmented on the basis of Product Type, End-Use, Regions
To get latest version of diabetes diagnostics market report can be obtained on demand from the website.